Hanmi Pharm’s Olita available for insurance benefits from coming 15th
The Ministry of Health and Welfare(Minister Neung-Hoo Park, MOHW) announced the ‘Drug Insurance Benefits List and Upper Limit Price Table’ had been revised and the Hanmi Pharm’s targeted therapy for non-small cell lung cancer ‘Olita Tab(generic name: olmutinib)’ would be applied to the health ins...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.